Digestive Diseases and Sciences

, Volume 63, Issue 5, pp 1368–1369 | Cite as

Hepatic Encephalopathy and Helicobacter pylori

Correspondence
  • 54 Downloads

Notes

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. 1.
    Wijarnpreecha K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, Ungprasert P, Cheungpasitporn W. Association of Helicobacter pylori with the risk of hepatic encephalopathy. Dig Dis Sci. 2017;62:3614–3621.  https://doi.org/10.1007/s10620-017-4834-1 CrossRefPubMedGoogle Scholar
  2. 2.
    Elizalde JI, Gómez J, Panés J, Lozano M, et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Investig. 1997;100:996–1005.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124:1846–1854.CrossRefPubMedGoogle Scholar
  4. 4.
    Innocenti M, Thoreson AC, Ferrero RL, Strömberg E, et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun. 2002;70:4581–4590.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Dundon WG, Nishioka H, Polenghi A, Papinutto E, et al. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol. 2002;291:545–550.CrossRefPubMedGoogle Scholar
  6. 6.
    Kutuk O, Basaga H. Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med. 2003;9:549–557.CrossRefPubMedGoogle Scholar
  7. 7.
    DaneshJ Kaptoge S, Mann AG, Sarwar N, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5(4):e78.  https://doi.org/10.1371/journal.pmed.0050078.CrossRefGoogle Scholar
  8. 8.
    Consolazio A, Borgia MC, Ferro D, Iacopini F, et al. Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther. 2004;20:289–294.CrossRefPubMedGoogle Scholar
  9. 9.
    Siringo S, Vaira D, Menegatti M, Piscaglia F, et al. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci. 1997;42:2024–2030.  https://doi.org/10.1023/A:1018849930107 CrossRefPubMedGoogle Scholar
  10. 10.
    Leone N, Pellicano R, Brunello M, Berrutti M, et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev. 2003;27:494–497.CrossRefPubMedGoogle Scholar
  11. 11.
    Wang L, Zollinger T, Zhang J. Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties. Cancer Causes Control. 2013;24:1331–1337.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical SciencesUniversity of TurinTurinItaly
  2. 2.Department of Medical and Surgical SciencesUniversity of Bologna, S. Orsola HospitalBolognaItaly

Personalised recommendations